145 related articles for article (PubMed ID: 36346459)
1. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
Xu B; Lubin DJ; Dogan S; Ghossein RA; Viswanathan K
Virchows Arch; 2023 Mar; 482(3):479-491. PubMed ID: 36346459
[TBL] [Abstract][Full Text] [Related]
2. The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile.
Metovic J; Vignale C; Annaratone L; Osella-Abate S; Maletta F; Rapa I; Cabutti F; Patriarca S; Gallo M; Nikiforov YE; Volante M; Papotti M
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32936917
[TBL] [Abstract][Full Text] [Related]
3. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
[TBL] [Abstract][Full Text] [Related]
4. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
[TBL] [Abstract][Full Text] [Related]
5. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
6. Follicular histotypes of oncocytic thyroid carcinomas do not carry mutations of the BRAF hot-spot.
Musholt PB; Musholt TJ; Morgenstern SC; Worm K; Sheu SY; Schmid KW
World J Surg; 2008 May; 32(5):722-8. PubMed ID: 18235983
[TBL] [Abstract][Full Text] [Related]
7. Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update.
Bischoff LA; Ganly I; Fugazzola L; Buczek E; Faquin WC; Haugen BR; McIver B; McMullen CP; Newbold K; Rocke DJ; Russell MD; Ryder M; Sadow PM; Sherman E; Shindo M; Shonka DC; Singer MC; Stack BC; Wirth LJ; Wong RJ; Randolph GW
JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):265-272. PubMed ID: 38206595
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.
Wenter V; Albert NL; Unterrainer M; Ahmaddy F; Ilhan H; Jellinek A; Knösel T; Bartenstein P; Spitzweg C; Lehner S; Todica A
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):449-460. PubMed ID: 32683470
[TBL] [Abstract][Full Text] [Related]
9. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
10. Poorly differentiated oncocytic thyroid carcinoma--diagnostic implications and outcome.
Dettmer M; Schmitt A; Steinert H; Moch H; Komminoth P; Perren A
Histopathology; 2012 Jun; 60(7):1045-51. PubMed ID: 22348590
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and outcomes after radioactive iodine treatment of oncocytic well-differentiated thyroid carcinomas.
Amouri W; Charfeddine S; Charfi S; Jardak I; Boudawara T; Guermazi F
Nucl Med Commun; 2019 Sep; 40(9):888-893. PubMed ID: 31343615
[TBL] [Abstract][Full Text] [Related]
12. [Poorly differentiated thyroid carcinoma : An underdiagnosed entity. German version].
Dettmer MS; Schmitt A; Komminoth P; Perren A
Pathologe; 2019 May; 40(3):227-234. PubMed ID: 31093689
[TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated thyroid carcinoma : An underdiagnosed entity.
Dettmer MS; Schmitt A; Komminoth P; Perren A
Pathologe; 2020 Jun; 41(Suppl 1):1-8. PubMed ID: 31273418
[TBL] [Abstract][Full Text] [Related]
14. Oncocytic Change in Thyroid Pathology.
Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():678119. PubMed ID: 34012422
[TBL] [Abstract][Full Text] [Related]
15. High-Grade Non-Anaplastic Thyroid Carcinomas of Follicular Cell Origin: A Review of Poorly Differentiated and High-Grade Differentiated Carcinomas.
Cracolici V; Cipriani NA
Endocr Pathol; 2023 Mar; 34(1):34-47. PubMed ID: 36692728
[TBL] [Abstract][Full Text] [Related]
16. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
17. Aneuploidy in oncocytic lesions of the thyroid gland: diffuse accumulation of mitochondria within the cell is associated with trisomy 7 and progressive numerical chromosomal alterations.
Dettori T; Frau DV; Lai ML; Mariotti S; Uccheddu A; Daniele GM; Tallini G; Faa G; Vanni R
Genes Chromosomes Cancer; 2003 Sep; 38(1):22-31. PubMed ID: 12874783
[TBL] [Abstract][Full Text] [Related]
18. Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
Matsuura D; Yuan A; Wang L; Ranganath R; Adilbay D; Harries V; Patel S; Tuttle M; Xu B; Ghossein R; Ganly I
Thyroid; 2022 Mar; 32(3):245-254. PubMed ID: 35078345
[No Abstract] [Full Text] [Related]
19. Re-evaluation of histopathological factors affecting prognosis of differentiated thyroid carcinoma in an iodine-sufficient country.
Sugitani I; Toda K; Yamamoto N; Sakamoto A; Fujimoto Y
World J Surg; 2010 Jun; 34(6):1265-73. PubMed ID: 19953247
[TBL] [Abstract][Full Text] [Related]
20. Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference?
Tsybrovskyy O; Rössmann-Tsybrovskyy M
Histopathology; 2009 Dec; 55(6):665-82. PubMed ID: 20002768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]